153 related articles for article (PubMed ID: 36075788)
1. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
4. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
6. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
7. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
8. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
Xue B; Li S; Jin X; Liu L
BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets of metformin against ovarian cancer based on network pharmacology.
Guo JY; Wang YJ; Li SQ; Wu YP
Chem Biol Drug Des; 2023 Jul; 102(1):88-100. PubMed ID: 36977503
[TBL] [Abstract][Full Text] [Related]
11. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
[TBL] [Abstract][Full Text] [Related]
12. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Yang L; Jing J; Sun L; Yue Y
Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics.
Dong C; Tian X; He F; Zhang J; Cui X; He Q; Si P; Shen Y
J Ovarian Res; 2021 Jul; 14(1):92. PubMed ID: 34253236
[TBL] [Abstract][Full Text] [Related]
14. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
Zheng Q; Ye H; Zhong H; Wang M
Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.
Wei M; Bai X; Dong Q
Transl Cancer Res; 2022 Jun; 11(6):1630-1643. PubMed ID: 35836518
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis of key pathways and genes shared between endometriosis and ovarian cancer.
Ni L; Chen Y; Yang J; Chen C
Arch Gynecol Obstet; 2022 May; 305(5):1329-1342. PubMed ID: 34727222
[TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
18. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
19. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
[TBL] [Abstract][Full Text] [Related]
20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
